» Articles » PMID: 1532289

Six Novel Deleterious and Three Neutral Mutations in the Gene Encoding the Alpha-subunit of Hexosaminidase A in Non-Jewish Individuals

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 1992 Apr 1
PMID 1532289
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Initial investigations demonstrated that only 3/34 "Tay-Sachs chromosomes" in 22 unrelated, non-Jewish patients or carriers of some form of GM2-gangliosidosis (7 black and 15 non-Jewish Caucasian) had either of the two mutations commonly found in the Jewish population. To determine the nature and incidence of the alterations in this non-Jewish population we have utilized PCR, single-strand conformation polymorphism analysis and sequencing to detect new mutations in genomic DNA. Fourteen primer sets have been utilized to analyze 80% of the coding region and 23/26 splice sites of the gene coding for the alpha chain of hexosaminidase A. Presumed deleterious mutations were discovered in 17/34 chromosomes believed to be carrying a beta-hexosaminidase A alpha-subunit gene mutation. Ten had abnormalities which have been described previously. In the remaining 24 Tay-Sachs disease alleles, six novel mutations predicted to be deleterious were discovered. These include two small deletions (a single-base frameshift and a three-base deletion removing an amino acid), two different nonsense mutations, an initiation codon mutation (ATG----GTG), and a missense mutation (Arg499Cys) in a highly conserved residue. In addition, three presumed nondeleterious mutations were found.

Citing Articles

Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum.

Ibrahim D, Ali O, Nasr H, Fateen E, Abdelaleem A Orphanet J Rare Dis. 2023; 18(1):52.

PMID: 36907859 PMC: 10009996. DOI: 10.1186/s13023-023-02637-1.


Identification of novel variants in a large cohort of children with Tay-Sachs disease: An initiative of a multicentric task force on lysosomal storage disorders by Government of India.

Mistri M, Mehta S, Solanki D, Kamate M, Gupta N, Kabra M J Hum Genet. 2019; 64(10):985-994.

PMID: 31388111 DOI: 10.1038/s10038-019-0647-8.


Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling.

Ou L, Kim S, Whitley C, Jarnes-Utz J Mol Genet Metab Rep. 2019; 20:100495.

PMID: 31367523 PMC: 6646740. DOI: 10.1016/j.ymgmr.2019.100495.


Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population.

Mehta N, Lazarin G, Spiegel E, Berentsen K, Brennan K, Giordano J Genet Test Mol Biomarkers. 2016; 20(9):504-9.

PMID: 27362553 PMC: 5314723. DOI: 10.1089/gtmb.2015.0302.


Tay-Sachs disease preconception screening in Australia: self-knowledge of being an Ashkenazi Jew predicts carrier state better than does ancestral origin, although there is an increased risk for c.1421 + 1G > C mutation in individuals with South....

Lew R, Burnett L, Proos A J Community Genet. 2011; 2(4):201-9.

PMID: 22109873 PMC: 3215783. DOI: 10.1007/s12687-011-0057-x.


References
1.
Nakano T, Nanba E, Tanaka A, Ohno K, Suzuki Y, Suzuki K . A new point mutation within exon 5 of beta-hexosaminidase alpha gene in a Japanese infant with Tay-Sachs disease. Ann Neurol. 1990; 27(5):465-73. DOI: 10.1002/ana.410270503. View

2.
Tanaka A, Ohno K, Sandhoff K, Maire I, Kolodny E, Brown A . GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients. Am J Hum Genet. 1990; 46(2):329-39. PMC: 1684994. View

3.
Feigenbaum A, Natowicz M, Skomorowski M, Schuster S, Clarke J, Mahuran D . Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. N Engl J Med. 1990; 323(1):6-12. DOI: 10.1056/NEJM199007053230102. View

4.
Navon R, Proia R . The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. Science. 1989; 243(4897):1471-4. DOI: 10.1126/science.2522679. View

5.
Lau M, Neufeld E . A frameshift mutation in a patient with Tay-Sachs disease causes premature termination and defective intracellular transport of the alpha-subunit of beta-hexosaminidase. J Biol Chem. 1989; 264(35):21376-80. View